What is Therapeutics?
Therapeutics Inc. operates as a specialized dermatology Contract Research Organization (CRO), providing integrated, turnkey solutions for drug development. With over two decades of experience, the company excels in navigating the intricate non-clinical, clinical, and regulatory processes essential for bringing new dermatological treatments to market. Their commitment to clarity and collaboration aims to enhance the efficiency of dermatology drug development. Therapeutics Inc. offers comprehensive services spanning product development, clinical development, and regulatory affairs, all meticulously tailored to the specific requirements of their clientele. The organization's strategic focus is on fostering seamless communication and workflow management to ensure high stakeholder satisfaction and facilitate successful regulatory approvals.
How much funding has Therapeutics raised?
Therapeutics has raised a total of $2.3M across 2 funding rounds:
Debt
$1M
Debt
$1.3M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.3M led by PPP
Key Investors in Therapeutics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Therapeutics?
The substantial enterprise-level funding and recent strategic investment signal that Therapeutics Inc. is likely in a scaling or expansion phase, potentially focusing on broadening its service offerings, increasing its operational capacity, or entering new market segments within the dermatology CRO landscape. This significant capital infusion is expected to accelerate its mission to streamline and improve the drug development pipeline for dermatological therapies, positioning the company for further growth and market leadership.
See full Therapeutics company page
